In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Affymetrix and IPSOGEN Collaborate to Develop and Market In-Vitro Diagnostic Cancer Tests
Affymetrix and IPSOGEN Collaborate to Develop and Market In-Vitro Diagnostic Cancer Tests
Partners HealthCare and Affymetrix collaborate to develop microarray diagnostics
Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products
Affymetrix Enters Into Licensing Deal With Empire Genomics - Quick Facts [AFFX]
Affymetrix and QIAGEN to collaborate on siRNA research
Affymetrix and PathWork Informatics forge collaboration to develop new cancer diagnostics
Affymetrix and Sysmex join forces to develop and market in-vitro diagnostic tests
Spectral Genomics Receives License From Affymetrix for Nucleic Acid Arrays In The Diagnostic Market
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
